dr. Renée Bultijnck

Androgen deprivation therapy in advanced prostate cancer : insights from a real-world patient survey on health-related quality of life and information and communication sources

Renée Bultijnck (UGent) , Luc De Laere, Rony De Grande, Thijs Develter, Sophie Vantieghem, Pieter Uvin, Christophe Ghysel, Bram De Laere (UGent) and [missing] the patient organization Think Blue Vlaanderen vzw

(2024) QUALITY OF LIFE RESEARCH.

Add to list

Journal Article
A1
open access

Nonpharmacological interventions for managing the dyspnea-fatigue-physical/role functioning symptom cluster in lung cancer patients : a systematic review

Clara Leyns (UGent) , Cassandra Van Boterdael, Ellen Baele (UGent) , Lindsay Poppe (UGent) , Charlotte Billiet, Renée Bultijnck (UGent) , Maarten Lambrecht, Yolande Lievens (UGent) and Elke Rammant (UGent)

(2024) EUROPEAN JOURNAL OF CANCER CARE. 2024. p.1-24

Add to list

Journal Article
A1
open access

Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy : real-world data from the E2-RADIatE OligoCare cohort

Renée Bultijnck (UGent) , Mieke Van Hemelrijck, Valerie Fonteyne (UGent) , Lorenzo Livi, Barbara Alicja Jereczek-Fossa, Hossein Hemmatazad, Michael Mayinger, Heike Peulen, Luc Verbeke, Sara Ramella, et al.

(2024) CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 45.

Add to list

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

Piet Ost (UGent) , Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, François-Xavier Otte, Alfonso Gomez-Iturriaga, Wouter Everaerts, Mohamed Shelan, Antonio Conde-Moreno, et al.

(2024) EUROPEAN UROLOGY ONCOLOGY. 7(3). p.462-468

Add to list

Journal Article
A2
open access

Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

Elnaz Naderi, Miguel E Aguado-Barrera, Line M H Schack, Leila Dorling, Tim Rattay, Laura Fachal, Holly Summersgill, Laura Martínez-Calvo, Ceilidh Welsh, Tom Dudding, et al.

(2023) JNCI CANCER SPECTRUM. 7(6).

Add to list

Vaginal morbidity, sexual functioning, and health-related quality of life in cervical cancer survivors : a cross-sectional multicenter study (VAMOS)

Eline Naert (UGent) , Alexander Decruyenaere (UGent) , Renée Bultijnck (UGent) , Emiel De Jaeghere (UGent) , Marjolein Orije (UGent) , Rawand Salihi (UGent) , Hans Verstraelen (UGent) , Philippe Tummers (UGent) , Hannelore Denys (UGent) and Katrien Vandecasteele (UGent)

(2023) SUPPORTIVE CARE IN CANCER. 31(12).

Add to list

Journal Article
A1
open access

Patient-reported outcomes and functional exercise capacity in a real-life setting in non-small cell lung cancer patients undergoing stereotactic body radiotherapy : the Lung PLUS study

Lotte van der Weijst, Renée Bultijnck (UGent) , Axel Van Damme, Vincent Huybrechts (UGent) , Marc Van Eijkeren (UGent) and Yolande Lievens (UGent)

(2023) FRONTIERS IN ONCOLOGY. 13.

Add to list

Journal Article
A1
open access

Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data : dosimetry, acute and two years physician and patient-reported outcomes

Vincent Vakaet (UGent) , Pieter Deseyne, Renée Bultijnck (UGent) , Giselle Post (UGent) , Catharine West, David Azria, Celine Bourgier, Marie-Pierre Farcy-Jacquet, Barry Rosenstein, Sheryl Green, et al.

(2023) ACTA ONCOLOGICA. 62(9). p.1036-1044

Add to list

Journal Article
A1
open access

Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer

Harkeran K. Jandu, Colin D. Veal, Laura Fachal, Craig Luccarini, Miguel E. Aguado-Barrera, Manuel Altabas, David Azria, Adinda Baten, Celine Bourgier, Renée Bultijnck (UGent) , et al.

(2023) RADIOTHERAPY AND ONCOLOGY. 187.

Add to list

Journal Article
A1
open access

Experiences of men with prostate cancer participating in a clinical pathway with a supervised group-based exercise program to combat androgen deprivation-induced side effects : a qualitative focus group study

Renée Bultijnck (UGent) , Elke Rammant (UGent) , Anneleen Raes (UGent) , Nathalie Vandecasteele (UGent) , Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , Nicolaas Lumen (UGent) , Piet Ost (UGent) and Benedicte Deforche (UGent)

(2023) SEMINARS IN ONCOLOGY NURSING. 39(3).

Academic Bibliography

dr. Renée Bultijnck

Androgen deprivation therapy in advanced prostate cancer : insights from a real-world patient survey on health-related quality of life and information and communication sources

Nonpharmacological interventions for managing the dyspnea-fatigue-physical/role functioning symptom cluster in lung cancer patients : a systematic review

Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy : real-world data from the E2-RADIatE OligoCare cohort

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

Vaginal morbidity, sexual functioning, and health-related quality of life in cervical cancer survivors : a cross-sectional multicenter study (VAMOS)

Patient-reported outcomes and functional exercise capacity in a real-life setting in non-small cell lung cancer patients undergoing stereotactic body radiotherapy : the Lung PLUS study

Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data : dosimetry, acute and two years physician and patient-reported outcomes

Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer

Experiences of men with prostate cancer participating in a clinical pathway with a supervised group-based exercise program to combat androgen deprivation-induced side effects : a qualitative focus group study

Contents

Support

Contact